Annexon Inc reports results for the quarter ended September 30 - Earnings Summary

Annexon

14/11/2024 20:54

* Annexon Inc  ANNX.OQ  reported a quarterly adjusted loss
of 25
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -43 cents.  The mean expectation of eight analysts for the
quarter was for a loss of 26 cents per share. Wall Street
expected results to range from -31 cents to -22 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Annexon Inc's reported EPS for the quarter was a loss
of 25
cents​.
    * The company reported a quarterly loss of $34.82 million.
    * Annexon Inc shares had risen by 10.6% this quarter and
gained 44.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Annexon Inc is
13.00 
This summary was machine generated from LSEG data November 14 at
08:54 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.26          -0.25          Beat
 Jun. 30 2024      -0.23          -0.23          Met
 Mar. 31 2024      -0.34          -0.21          Beat
 Dec. 31 2023      -0.44          -0.36          Beat